Home Newsletters Editor´s Pick

Editor´s Pick

Most popular

First Patient Treated in Alpha-1 Antitrypsin Deficiency Liver Disease Phase 3 Study Triggering $40 Million Milestone Payment from Takeda to Arrowhead

Admin - April 4, 2023

Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy

Rocket Lab Spacecraft Built for Varda Successfully Operating on Orbit

Bayer Announces Senior Bayer Representative and President of Bayer U.S.

Meissa Vaccines Announces Positive Clinical Data for the First RSV Vaccine...

Admin - August 8, 2023 0

Mahana Therapeutics Signs Agreement with Consumer Health Division of Bayer to...

Admin - August 22, 2023 0

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19...

Admin - August 30, 2023 0

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

Admin - September 12, 2023 0

Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against...

Admin - September 19, 2023 0

Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib for the...

Admin - September 22, 2023 0